Cited by 317Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

The DOI matches its Crossref record; 252 of the 258 references it cites were found in a registry or an index.

7. Diabetes Technology: Standards of Care in Diabetes — 2023

Open access

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E., Isaacs, Diana, Johnson, Eric L., Kahan, Scott, Khunti, Kamlesh, Leon, Jose, Lyons, Sarah K., Perry, Mary Lou, Prahalad, Priya, Pratley, Richard E., Seley, Jane Jeffrie, Stanton, Robert C., Gabbay, Robert A.·2023·Diabetes Care

DOI 10.2337/dc23-s007PMC PMC9810474

Open this paper in CoChat — free account Open PDF

Abstract

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dc23-s007

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT): a multicentre international randomised controlled trial
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 630
Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose
Parkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543
Self-citation
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 496
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-analysis
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial
Laffel, L. M., Kanapka, L. G., Beck, R. W., Bergamo, K., Clements, M. A., Criego, A., DeSalvo, D. J., Goland, R., Hood, K., Liljenquist, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6940 · Cited by 443
Self-citation
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Tauschmann, M., Thabit, H., Bally, L., Allen, J. M., Hartnell, S., Wilinska, M. E., Ruan, Y., Sibayan, J., Kollman, C., Cheng, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31947-0 · Cited by 440
Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S. K., Zisser, H., Schwartz, S. L., Bailey, T. S., Kaplan, R. A., Ellis, S. L., & Jovanovič, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 429
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial
Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., & Neil, A. (2007) · BMJ · doi:10.1136/bmj.39247.447431.be · Cited by 407
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial
Pratley, R. E., Kanapka, L. G., Rickels, M. R., Ahmann, A., Aleppo, G., Beck, R., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.6928 · Cited by 375
Self-citation
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis
Jeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine
Doyle (Boland), E. A., Weinzimer, S. A., Steffen, A. T., Ahern, J. A. H., Vincent, M., & Tamborlane, W. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1554 · Cited by 373
Racial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Factors affecting blood glucose monitoring: sources of errors in measurement
Ginsberg, B. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300438 · Cited by 348
Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes
Ziegler, R., Heidtmann, B., Hilgard, D., Hofer, S., Rosenbauer, J., Holl, R., & DPV-Wiss-Initiative, F. T. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00650.x · Cited by 334
REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329
Self-citation
Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
O’Kane, M. J., Bunting, B., Copeland, M., & Coates, V. E. (2008) · BMJ · doi:10.1136/bmj.39534.571644.be · Cited by 326
Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline
Korytkowski, M. T., Muniyappa, R., Antinori-Lent, K., Donihi, A. C., Drincic, A. T., Hirsch, I. B., Luger, A., McDonnell, M. E., Murad, M. H., Nielsen, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac278 · Cited by 315
Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
New insulin delivery recommendations
Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286
A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
Korytkowski, M., Bell, D., Jacobsen, C., Suwannasari, R., & FlexPen® Study Team (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80337-5 · Cited by 267
Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study
Charleer, S., De Block, C., Van Huffel, L., Broos, B., Fieuws, S., Nobels, F., Mathieu, C., & Gillard, P. (2020) · Diabetes Care · doi:10.2337/dc19-1610 · Cited by 261
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 260
Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline
Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2534 · Cited by 250
Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246
A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia
Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244
Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens in Children With Type 1 Diabetes: A Randomized Open Crossover Trial
Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., Lilos, P., Dickerman, Z., & Phillip, M. (2003) · PEDIATRICS · doi:10.1542/peds.112.3.559 · Cited by 236
Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries
Sherr, J. L., Hermann, J. M., Campbell, F., Foster, N. C., Hofer, S. E., Allgrove, J., Maahs, D. M., Kapellen, T. M., Holman, N., Tamborlane, W. V., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3790-6 · Cited by 236
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): A randomised open-label controlled trial
Reznik, Y., Cohen, O., Aronson, R., Conget, I., Runzis, S., Castaneda, J., & Lee, S. W. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61037-0 · Cited by 233
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Carlson, A. L., Sherr, J. L., Shulman, D. I., Garg, S. K., Pop-Busui, R., Bode, B. W., Lilenquist, D. R., Brazg, R. L., Kaiserman, K. B., Kipnes, M. S., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0319 · Cited by 230
Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany
Maahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0780 · Cited by 224
Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes
Plotnick, L. P., Clark, L. M., Brancati, F. L., & Erlinger, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1142 · Cited by 216
One year clinical experience of the first commercial hybrid closed-loop system
Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019) · Diabetes Care · doi:10.2337/dc19-0855 · Cited by 215
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Care · doi:10.2337/dc12-2360 · Cited by 214
Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial
O’Connell, M. A., Donath, S. M., O'Neal, D. N., Colman, P. G., Ambler, G. R., Jones, T. W., Davis, E. A., & Cameron, F. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1365-0 · Cited by 212
Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes
Yaron, M., Roitman, E., Aharon-Hananel, G., Landau, Z., Ganz, T., Yanuv, I., Rozenberg, A., Karp, M., Ish-Shalom, M., Singer, J., et al. (2019) · Diabetes Care · doi:10.2337/dc18-0166 · Cited by 211
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
Kristensen, K., Ögge, L. E., Sengpiel, V., Kjölhede, K., Dotevall, A., Elfvin, A., Knop, F. K., Wiberg, N., Katsarou, A., Shaat, N., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4850-0 · Cited by 210
Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
Simon, J., Gray, A., Clarke, P., Wade, A., Neil, A., & Farmer, A. (2008) · BMJ · doi:10.1136/bmj.39526.674873.be · Cited by 206
Smartphone apps for calculating insulin dose: a systematic assessment
Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K., & Car, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0314-7 · Cited by 200
The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199
Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor
Herman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes
Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K., & Dlott, R. (2021) · JAMA · doi:10.1001/jama.2021.6530 · Cited by 191
Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: A systematic review of randomised controlled trials and meta-analysis
Teo, E., Hassan, N., Tam, W., & Koh, S. (2022) · Diabetologia · doi:10.1007/s00125-021-05648-4 · Cited by 186
Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
Forlenza, G. P., Pinhas‐Hamiel, O., Liljenquist, D. R., Shulman, D. I., Bailey, T. S., Bode, B. W., Wood, M. A., Buckingham, B. A., Kaiserman, K. B., Shin, J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0264 · Cited by 184
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Garg, S. K., Kipnes, M., Castorino, K., Bailey, T. S., Akturk, H. K., Welsh, J. B., Christiansen, M. P., Balo, A. K., Brown, S. A., Reid, J. L., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0011 · Cited by 179
Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) nationwide audit
Deshmukh, H., Wilmot, E. G., Gregory, R., Barnes, D., Narendran, P., Saunders, S., Furlong, N., Kamaruddin, S., Banatwalla, R., Herring, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0738 · Cited by 175
Intermittently scanned continuous glucose monitoring for type 1 diabetes
Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205650 · Cited by 174
Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study
Roussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline
Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820954163 · Cited by 170
Self-citation
Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes
Tyndall, V., Stimson, R. H., Zammitt, N. N., Ritchie, S. A., McKnight, J. A., Dover, A. R., & Gibb, F. W. (2019) · Diabetologia · doi:10.1007/s00125-019-4894-1 · Cited by 165
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
Visser, M. M., Charleer, S., Fieuws, S., De Block, C., Hilbrands, R., Van Huffel, L., Maes, T., Vanhaverbeke, G., Dirinck, E., Myngheer, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00789-3 · Cited by 165
Accuracy of Dexcom G6 continuous glucose monitoring in non-critically ill hospitalized patients with diabetes
Davis, G. M., Spanakis, E. K., Migdal, A. L., Singh, L. G., Albury, B., Urrutia, M. A., Zamudio-Coronado, K. W., Scott, W. H., Doerfler, R., Lizama, S., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2856 · Cited by 160
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
Barnard, K. D., Wysocki, T., Allen, J. M., Elleri, D., Thabit, H., Leelarathna, L., Gulati, A., Nodale, M., Dunger, D. B., Tinati, T., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000025 · Cited by 159
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001115 · Cited by 157
Implementation of continuous glucose monitoring in the hospital: Emergent considerations for remote glucose monitoring during the COVID-19 pandemic
Galindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820932903 · Cited by 155
Self-citation
Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial
Young, L. A., Buse, J. B., Weaver, M. A., Vu, M. B., Mitchell, C. M., Blakeney, T., Grimm, K., Rees, J., Niblock, F., Donahue, K. E., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1233 · Cited by 148
Effect of a mobile phone-based glucose-monitoring and feedback system for type 2 diabetes management in multiple primary care clinic settings: cluster randomized controlled trial
Yang, Y., Lee, E. Y., Kim, H.-S., Lee, S.-H., Yoon, K.-H., & Cho, J.-H. (2020) · JMIR mHealth and uHealth · doi:10.2196/16266 · Cited by 148
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
Arab, J. P., Dirchwolf, M., Álvares‐da‐Silva, M. R., Francisco Barrera, M., Benítez, C., Castellanos, M., Castro‐Narro, G., Chávez-Tapia, N. C., Chiodi, D., Cotrim, H. P., et al. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.09.006 · Cited by 146
Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: The CORRIDA Randomized Controlled Trial
Hásková, A., Radovnická, L., Petruželková, L., Parkin, C. G., Grunberger, G., Horová, E., Navrátilová, V., Kádě, O., Matoulek, M., Prázný, M., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0112 · Cited by 146
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A. (2018) · Diabetes Care · doi:10.2337/dc17-1960 · Cited by 144
Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards
Sepah, S. C., Jiang, L., & Peters, A. L. (2014) · The Diabetes Educator · doi:10.1177/0145721714531339 · Cited by 139
Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic
Agarwal, S., Mathew, J., Davis, G. M., Shephardson, A., Levine, A., Louard, R., Urrutia, A., Perez-Guzman, C., Umpierrez, G. E., Peng, L., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2219 · Cited by 138
The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction
Phillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135
History and Perspective on DIY Closed Looping
Lewis, D. M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818808307 · Cited by 132
Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes
Sherr, J. L., Cengiz, E., Palerm, C. C., Clark, B., Kurtz, N., Roy, A., Carria, L., Cantwell, M., Tamborlane, W. V., & Weinzimer, S. A. (2013) · Diabetes Care · doi:10.2337/dc13-0010 · Cited by 125
Five things physicians and patients should question.
(2013) · PubMed · Cited by 123
Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy
Wright, E. E., Kerr, M. S. D., Reyes, I. J., Nabutovsky, Y., & Miller, E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0069 · Cited by 115
Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch
Stone, M. P., Agrawal, P. K., Chen, X., Liu, M., Shin, J., Cordero, T. L., & KAUFMAN, F. R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0202 · Cited by 114
Health Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database Analysis
Pawaskar, M. D., CAMACHO, F. T., Anderson, R. T., Cobden, D., Joshi, A. V., & Balkrishnan, R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.007 · Cited by 111
Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy
Kordonouri, O., Hartmann, R., Remus, K., Bläsig, S., Sadeghian, E., & Danne, T. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00880.x · Cited by 108
Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial
Forlenza, G. P., Ekhlaspour, L., Breton, M. D., Maahs, D. M., Wadwa, R. P., DeBoer, M. D., Messer, L. H., Town, M., Pinnata, J., Kruse, G., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0011 · Cited by 108
Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors
REDONDO, M. J., Libman, I. M., Cheng, P., Kollman, C., Tosur, M., Gal, R. L., Bacha, F. F., KLINGENSMITH, G. J., Clements, M. A., REDONDO, M. J., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2335 · Cited by 104
Self-citation
Lipohypertrophy in Young Patients With Type 1 Diabetes
Kordonouri, O., Lauterborn, R., & Deiss, D. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.634 · Cited by 103
Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus
Breton, M. D., Patek, S. D., Lv, D., Schertz, E. M., Robic, J., Pinnata, J., Kollar, L. L., Barnett, C. L., WAKEMAN, C. A., Oliveri, M. C., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0079 · Cited by 102
Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial
Tumminia, A., Crimi, S., Sciacca, L., Buscema, M., Frittitta, L., Squatrito, S., Vigneri, R., & Tomaselli, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2557 · Cited by 100
Effect of a CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: a randomized controlled trial
WEI, Q., SUN, Z., YANG, Y., YU, H., DING, H., & WANG, S. (2016) · Scientific Reports · doi:10.1038/srep19920 · Cited by 99
A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with fingerstick blood glucose monitoring in very young children with type 1 diabetes
Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group, Laffel, L., Harrington, K., Hanono, A., Naik, N., Ambler-Osborn, L., Schultz, A., DiMeglio, L., Woerne, S., Jolivette, H., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1060 · Cited by 95
Self-citation
Treat-to-target trials: uses, interpretation and review of concepts
Garber, A. J. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12129 · Cited by 94
Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: Proof of concept
Davis, G. M., Faulds, E., Walker, T., Vigliotti, D., Rabinovich, M., Hester, J., Peng, L., McLean, B., Hannon, P., Poindexter, N., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2085 · Cited by 94
Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis
Karageorgiou, V., Papaioannou, T., Bellos, I., Alexandraki, K., Tentolouris, N., Stefanadis, C., Chrousos, G. P., & Tousoulis, D. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.002 · Cited by 93
Safety and performance of the Omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions
Sherr, J. L., Buckingham, B. A., Forlenza, G. P., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., Carria, L., Hsu, L., Berget, C., Peyser, T. A., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0286 · Cited by 92
Managing diabetes in preschool children
Sundberg, F., Barnard, K., Cato, A., de Beaufort, C., DiMeglio, L. A., Dooley, G., Hershey, T., Hitchcock, J., Jain, V., Weissberg-Benchell, J., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12554 · Cited by 91
Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
Mannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719290 · Cited by 90
Use and accuracy of inpatient CGM during the COVID-19 pandemic: an observational study of general medicine and ICU patients
Longo, R. R., Elias, H., Khan, M., & Seley, J. J. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211008446 · Cited by 89
Self-citation
Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases: HAYNES et al.
Haynes, A., Hermann, J. M., Miller, K. M., Hofer, S. E., Jones, T. W., Beck, R. W., Maahs, D. M., Davis, E. A., Holl, R. W., & for the T1D Exchange, W. A. D. R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12477 · Cited by 88
Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial
Bergenstal, R. M., Johnson, M., Passi, R., Bhargava, A., Young, N., Kruger, D. F., Bashan, E., Bisgaier, S. G., Isaman, D. J. M., & Hodish, I. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30368-x · Cited by 88
Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients
Hyry, H., Liippo, J., & Virtanen, H. M. (2019) · Contact Dermatitis · doi:10.1111/cod.13337 · Cited by 87
Further evidence of severe allergic contact dermatitis from isobornyl acrylate while using a continuous glucose monitoring system
Kamann, S., Aerts, O., & Heinemann, L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818762946 · Cited by 85
Remote lifestyle coaching plus a connected glucose meter with certified diabetes educator support improves glucose and weight loss for people with type 2 diabetes
Bollyky, J. B., Bravata, D., Yang, J., Williamson, M., & Schneider, J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3961730 · Cited by 85
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
Kesavadev, J., Srinivasan, S., Saboo, B., Krishna B, M., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00823-z · Cited by 85
Continuous glucose monitoring in critically ill patients with COVID-19: Results of an emergent pilot study
Sadhu, A. R., Serrano, I. A., Xu, J., Nisar, T., Lucier, J., Pandya, A. R., & Patham, B. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820964264 · Cited by 84
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study
Garg, S. K., Liljenquist, D. R., Bode, B. W., Christiansen, M. P., Bailey, T. S., Brazg, R., Denham, D. S., Chang, A. R., Aktürk, H. K., DEHENNIS, A. D., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0182 · Cited by 84
Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance
Addala, A., Maahs, D. M., Scheinker, D., Chertow, S., Leverenz, B., & Prahalad, P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13082 · Cited by 83
Self-citation
Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study ( GLADIS )
New, J. P., Ajjan, R., Pfeiffer, A. F. H., & Freckmann, G. (2015) · Diabetic Medicine · doi:10.1111/dme.12713 · Cited by 83
Health economics and compliance of vials/syringes versus pen devices: a review of the evidence
Asche, C. V., Shane-McWhorter, L., & Raparla, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0180 · Cited by 83
Enhanced self-efficacy and behavioral changes among patients with diabetes: cloud-based mobile health platform and mobile app service
Chao, D. Y., Lin, T. M., & Ma, W.-Y. (2019) · JMIR Diabetes · doi:10.2196/11017 · Cited by 82
The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin
Aleppo, G., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1304 · Cited by 82
Self-citation
Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: the Pilot 4T Study
Prahalad, P., Ding, V. Y., Zaharieva, D. P., Addala, A., Johari, R., Scheinker, D., Desai, M., Hood, K., & Maahs, D. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab859 · Cited by 82
Self-citation
Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes
Lin, M. H., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Buckingham, B., Redondo, M. J., Schatz, D., Haro, H., Lee, J. M., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0132 · Cited by 81
Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies
Asarani, N. A. M., Reynolds, A. N., Styles, S. E., de Bock, M. I., & Wheeler, B. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870849 · Cited by 81
Evidence-based mHealth chronic disease mobile app intervention design: Development of a framework
Wilhide III, C. C., Peeples, M. M., & Anthony Kouyaté, R. C. (2016) · JMIR Research Protocols · doi:10.2196/resprot.4838 · Cited by 81
Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin
Bao, S., Bailey, R., Calhoun, P., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0494 · Cited by 81
A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits
Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819888662 · Cited by 80
Self-citation
Interference assessment of various endogenous and exogenous substances on the performance of the Eversense long-term implantable continuous glucose monitoring system
Lorenz, C., Sandoval, W., & Mortellaro, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0028 · Cited by 80
Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: a pilot, multicentre, randomised controlled trial
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79
Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial
Price, D. A., Deng, Q., Kipnes, M., & Beck, S. E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01086-y · Cited by 77
Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers
COMMISSARIAT, P. V., Boyle, C. T., Miller, K. M., Mantravadi, M., DeSalvo, D. J., Tamborlane, W. V., Name, M. A. V., Anderson, B. J., DiMeglio, L. A., & Laffel, L. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0375 · Cited by 77
Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system
Ekhlaspour, L., Forlenza, G. P., Cherñavvsky, D. R., Maahs, D. M., Wadwa, R. P., DeBoer, M. D., Messer, L. H., Town, M., Pinnata, J., Kruse, G., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12867 · Cited by 77
Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
Law, G. R., Gilthorpe, M. S., Secher, A. L., Temple, R., Bilous, R., Mathiesen, E. R., Murphy, H. R., & Scott, E. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4205-7 · Cited by 77
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
Champakanath, A., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2022) · Diabetes Care · doi:10.2337/dc21-2004 · Cited by 76
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin #2
Malanda, U., Bot, S., & Nijpels, G. (2013) · Rivm (National Institute for Public Health and the Environment) · doi:10.2337/dc12-0831document · Cited by 74
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Miller, K. M., Kanapka, L. G., Rickels, M. R., Ahmann, A. J., Aleppo, G., Ang, L., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0503 · Cited by 73
Self-citation
Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity
Petruželková, L., Šoupal, J., Plasova, V., Jiranova, P., Neuman, V., Plachý, L., Průhová, Š., Šumnı́k, Z., & Obermannová, B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0214 · Cited by 71
Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry
Wong, J. C., Boyle, C., DiMeglio, L. A., Mastrandrea, L. D., Abel, K.-L., Cengiz, E., Cemeroglu, P. A., Aleppo, G., Largay, J. F., Foster, N. C., et al. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663963 · Cited by 69
Self-citation
Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia
Anderson, S. M., Buckingham, B. A., Breton, M. D., Robic, J. L., Barnett, C. L., Wakeman, C. A., Oliveri, M. C., Brown, S. A., Ly, T. T., Clinton, P. K., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0018 · Cited by 68
Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers
Brazg, R. L., Klaff, L. J., & Parkin, C. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700117 · Cited by 68
Factors Related to Discontinuation of Continuous Subcutaneous Insulin-Infusion Therapy
Guinn, T. S., Bailey, G. J., & Mecklenburg, R. S. (1988) · Diabetes Care · doi:10.2337/diacare.11.1.46 · Cited by 66
Reviewing U.S. connected diabetes care: the newest member of the team
Levine, B. J., Close, K. L., & Gabbay, R. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0273 · Cited by 66
Self-citation
Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections
Riddlesworth, T., Price, D., Cohen, N., & Beck, R. W. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0281-4 · Cited by 65
Interferences with CGM systems: practical relevance?
Heinemann, L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211065065 · Cited by 65
Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus
Opipari-Arrigan, L., Fredericks, E. M., Burkhart, N., Dale, L., Hodge, M., & Foster, C. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00283.x · Cited by 64
Insulin pump-associated adverse events in children and adolescents–a prospective study
Wheeler, B. J., Heels, K., Donaghue, K. C., Reith, D. M., & Ambler, G. R. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0388 · Cited by 64
System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015
Pleus, S., Baumstark, A., Jendrike, N., Mende, J., Link, M., Zschornack, E., Haug, C., & Freckmann, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001067 · Cited by 63
Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes
Alemzadeh, R., Ellis, J. N., Holzum, M. K., Parton, E. A., & Wyatt, D. T. (2004) · Pediatrics · doi:10.1542/peds.114.1.e91 · Cited by 63
Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis
Lasalvia, P., Barahona-Correa, J. E., Romero-Alvernia, D. M., Gil-Tamayo, S., Castañeda-Cardona, C., Bayona, J. G., Triana, J. J., Laserna, A. F., Mejía-Torres, M., Restrepo-Jimenez, P., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633721 · Cited by 63
What Can We Learn from Patient-Reported Outcomes of Insulin Pen Devices?
Anderson, B. J., & REDONDO, M. J. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500633 · Cited by 63
Comparative Device Assessments
Ignaut, D. A., Schwartz, S. L., Sarwat, S., & Murphy, H. L. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709340056 · Cited by 62
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls
Nathanson, D., Svensson, A.-M., Miftaraj, M., Franzén, S., Bolinder, J., & Eeg-Olofsson, K. (2021) · Diabetologia · doi:10.1007/s00125-021-05437-z · Cited by 61
Randomized Controlled Trial of Mobile Closed-Loop Control
Kovatchev, B., Anderson, S. M., Raghinaru, D., Kudva, Y. C., Laffel, L. M., Levy, C., Pinsker, J. E., Wadwa, R. P., Buckingham, B., Doyle, F. J., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1310 · Cited by 60
A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice
Bailey, T. S., & Stone, J. Y. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1313831 · Cited by 60
Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis
REDONDO, M. J., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Wood, J., Buckingham, B. A., KLINGENSMITH, G. J., Silverstein, J. H., & Tamborlane, W. V. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12061 · Cited by 60
Impact of sensor-augmented pump therapy with predictive low-glucose suspend function on glycemic control and patient satisfaction in adults and children with type 1 diabetes
Beato-Víbora, P. I., Quirós-López, C., Lázaro-Martín, L., Martín-Frías, M., Barrio-Castellanos, R., Gil-Poch, E., Arroyo-Díez, F. J., & Giménez-Álvarez, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0199 · Cited by 60
Continuous glucose monitoring pilot in low-income type 1 diabetes patients
Sequeira, P. A., Montoya, L., Ruelas, V., Xing, D., Chen, V., Beck, R., & Peters, A. L. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0072 · Cited by 59
Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria
Berghaeuser, M., Kapellen, T., Heidtmann, B., Haberland, H., Klinkert, C., Holl, R., & for the DPV-Science-Initiative and the German working group for insulin pump treatment in paediatric patients (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00416.x · Cited by 58
Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus
Rigo, R. S., Levin, L. E., Belsito, D. V., Garzon, M. C., Gandica, R., & Williams, K. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820918894 · Cited by 58
Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: a randomized controlled trial
Yoo, J. H., Kim, G., Lee, H. J., Sim, K. H., Jin, S.-M., & Kim, J. H. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109209 · Cited by 58
The Evidence Base for Diabetes Technology: Appropriate and Inappropriate Meta-Analysis
Pickup, J. C. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700617 · Cited by 57
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Brown, S. A., Beck, R. W., Raghinaru, D., Buckingham, B. A., Laffel, L. M., Wadwa, R. P., Kudva, Y. C., Levy, C. J., Pinsker, J. E., Dassau, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0124 · Cited by 55
Effectiveness of internet-based interventions on glycemic control in patients with type 2 diabetes: meta-analysis of randomized controlled trials
Shen, Y., Wang, F., Zhang, X., Zhu, X., Sun, Q., Fisher, E., & Sun, X. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9133 · Cited by 54
Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years: Depression and pump discontinuation
Wong, J. C., Dolan, L. M., Yang, T. T., & Hood, K. K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12221 · Cited by 53
Effect of 6 months of flash glucose monitoring in youth with type 1 diabetes and high-risk glycemic control: a randomized controlled trial
Boucher, S. E., Gray, A. R., Wiltshire, E. J., de Bock, M. I., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., Chan, H., Rose, S., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0613 · Cited by 51
Dual Use of Department of Veterans Affairs and Medicare Benefits and Use of Test Strips in Veterans With Type 2 Diabetes Mellitus
Gellad, W. F., Zhao, X., Thorpe, C. T., Mor, M. K., Good, C. B., & Fine, M. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5405 · Cited by 51
Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A 1c and treatment modality
Birkebæk, N., Drivvoll, A., Aakesson, K., Bjarnason, R. G., Johansen, A., Samuelsson, U., Skrivarhaug, T., Þórsson, Á. V., & Svensson, J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000377 · Cited by 51
Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus
Patton, S. R., Noser, A. E., Youngkin, E. M., Majidi, S., & Clements, M. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0026 · Cited by 51
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study
Elliott, T., Beca, S. G., Beharry, R., Tsoukas, M. A., ZARRUK, A. R., & Abitbol, A. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211021374 · Cited by 51
Accuracy of continuous glucose monitors for inpatient diabetes management
Wright, J. J., Williams, A. J., Friedman, S. B., Weaver, R. G., Williams, J. M., Hodge, E., Fowler, M., & Bao, S. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221076562 · Cited by 49
Documentation of skin-related issues associated with continuous glucose monitoring use in the scientific literature
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47
Psychosocial impact of the bionic pancreas during summer camp
Weissberg-Benchell, J., Hessler, D., Polonsky, W. H., & Fisher, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816640289 · Cited by 47
Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes
Buckingham, B. A., Christiansen, M. P., Forlenza, G. P., Wadwa, R. P., Peyser, T. A., Lee, J. B., OCONNOR, J. B., Dassau, E., Huyett, L. M., Layne, J. E., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0138 · Cited by 47
Self-monitoring diabetes with multiple mobile health devices
Shaw, R. J., Yang, Q., Barnes, A. H., Hatch, D., Crowley, M. J. P., Vorderstrasse, A. A., Vaughn, J., Diane, A., Lewinski, A. A., Jiang, M., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa007 · Cited by 46
Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear
Yeh, T., Yeung, M., & Curanaj, F. A. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01375-7 · Cited by 46
Adherence to Insulin Pen Therapy Is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus.
Chandran, A., Bonafede, M. K., Nigam, S., Saltiel-Berzin, R., Hirsch, L. J., & Lahue, B. J. (2015) · PubMed Central · Cited by 44
Appearance of Do‐It‐Yourself closed‐loop systems to manage type 1 diabetes
Hng, T., & Burren, D. (2018) · Internal Medicine Journal · doi:10.1111/imj.14105 · Cited by 44
Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study
Deiss, D., Irace, C., Carlson, G., Tweden, K. S., & Kaufman, F. R. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0159 · Cited by 44
Intermittently scanned continuous glucose monitoring data of polish patients from real-life conditions: more scanning and better glycemic control compared to worldwide data
Hohendorff, J., Gumprecht, J., Mysliwiec, M., Zozulinska-Ziolkiewicz, D., & Malecki, M. T. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0034 · Cited by 43
Dosing Accuracy of Insulin Pens Versus Conventional Syringes and Vials
Luijf, Y. M., & DeVries, J. H. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0178 · Cited by 43
Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry
Sandig, D., Grimsmann, J. M., Reinauer, C., Melmer, A., Zimny, S., Müller-Korbsch, M., Forestier, N., Zeyfang, A., Bramlage, P., Danne, T., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0019 · Cited by 43
Improved HBa1c, total daily insulin dose, and treatment satisfaction with insulin pump therapy compared to multiple daily insulin injections in patients with type 2 diabetes irrespective of baseline c-peptide levels
Vigersky, R. A., Huang, S., Cordero, T. L., Shin, J., Lee, S. W., Chhabra, H., Kaufman, F. R., & Cohen, O. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0234 · Cited by 43
“I was ready for it at the beginning”: parent experiences with early introduction of continuous glucose monitoring following their child's type 1 diabetes diagnosis
Tanenbaum, M. L., Zaharieva, D. P., Addala, A., Ngo, J., Prahalad, P., Leverenz, B., New, C., Maahs, D. M., & Hood, K. K. (2021) · Diabetic Medicine · doi:10.1111/dme.14567 · Cited by 42
Self-citation
In-Hospital Management of Adults Using Insulin Pump Therapy
Houlden, R. L., & Moore, S. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.011 · Cited by 41
Characteristics relating to adherence and persistence to basal insulin regimens among elderly insulin-naïve patients with type 2 diabetes: pre-filled pens versus vials/syringes
Slabaugh, S. L., Bouchard, J. R., Li, Y., Baltz, J. C., Meah, Y. A., & Moretz, D. C. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0266-5 · Cited by 41
Perceptions of persons with type 2 diabetes treated in swedish primary health care: qualitative study on using eHealth services for self-management support
Öberg, U., Isaksson, U., Jutterström, L., Orre, C. J., & Hörnsten, Å. (2018) · JMIR Diabetes · doi:10.2196/diabetes.9059 · Cited by 41
Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor
Sanchez, P., Ghosh-Dastidar, S., Tweden, K. S., & Kaufman, F. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0234 · Cited by 40
Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes
Ushigome, E., Yamazaki, M., Hamaguchi, M., Ito, T., Matsubara, S., Tsuchido, Y., Kasamatsu, Y., Nakanishi, M., Fujita, N., & Fukui, M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0237 · Cited by 40
Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
Bergenstal, R. M., Peyrot, M. F., Dreon, D. M., Aroda, V. R., Bailey, T. S., Brazg, R., Frías, J. P., Johnson, M. L., Klonoff, D. C., Kruger, D. F., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0298 · Cited by 40
Self-citation
The Impact of Continuous Glucose Monitoring on Low Interstitial Glucose Values and Low Blood Glucose Values Assessed by Point-of-care Blood Glucose Meters: Results of a Crossover Trial
Hermanns, N., Schumann, B., Kulzer, B., & Haak, T. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524105 · Cited by 39
Using Digital Health Technology to Prevent and Treat Diabetes
Kaufman, N., & Dadashi, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.2506 · Cited by 39
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue
Lombardo, F., Salzano, G., Crisafulli, G., Panasiti, I., Alibrandi, A., Messina, M. F., Pajno, G. B., Caminiti, L., & Passanisi, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108089 · Cited by 39
Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes
Ahmann, A., Szeinbach, S. L., Gill, J., Traylor, L., & Garg, S. K. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0172 · Cited by 39
Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations
Leahy, J. L., Aleppo, G., Fonseca, V. A., Garg, S. K., Hirsch, I. B., McCall, A. L., McGill, J. B., & Polonsky, W. H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00222 · Cited by 38
Self-citation
Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care
Simonson, G. D., Bergenstal, R. M., Johnson, M. L., Davidson, J. L., & Martens, T. W. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821998724 · Cited by 37
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37
Insulin Pump Therapy from the Time of Diagnosis of Type 1 Diabetes
Ramchandani, N., Ten, S., Anhalt, H., SINHA, S. K., Ching, J., Finkelstein, A., & Maclaren, N. K. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.663 · Cited by 37
The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy
Oppel, E. M., Kamann, S., Heinemann, L., Reichl, F., & Högg, C. (2019) · Contact Dermatitis · doi:10.1111/cod.13392 · Cited by 37

Sorted by citations

Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis
Kerr, D., Ahn, D., Waki, K., Wang, J., Breznen, B., & Klonoff, D. C. (2024) · Journal of Medical Internet Research · doi:10.2196/55757 · Cited by 101
“…continuous glucose monitors, and connected insulin pens; digital interventions including mobile apps, SMS text messaging, electronic communications, and videoconference platforms; and wearable technologies for monitoring health, such as activity trackers, sleep trackers, and smartwatches [6,7].”
Diabetes and cirrhosis: Current concepts on diagnosis and management
Castéra, L., & Cusi, K. J. (2023) · Hepatology · doi:10.1097/hep.0000000000000263 · Cited by 87
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
Spanakis, E. K., Cook, C. B., Kulasa, K. M., Aloi, J., Bally, L., Davis, G. M., Dungan, K. M., Galindo, R. J., Mendez, C. E., Pasquel, F. J., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231191104 · Cited by 82
Advances in the management of type 2 diabetes in adults
Galindo, R. J., Trujillo, J. M., Wang, C. C. L., & McCoy, R. G. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000372 · Cited by 90
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 81

See all 317

Authors: ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
ORCID: ElSayed, Nuha A.
Aleppo, Grazia
Aroda, Vanita R.
Bannuru, Raveendhara R.
Brown, Florence M.
Bruemmer, Dennis
Collins, Billy S.
Hilliard, Marisa E.
Isaacs, Diana
Johnson, Eric L.
Kahan, Scott
Khunti, Kamlesh
Lyons, Sarah K.
Perry, Mary Lou
Prahalad, Priya
Pratley, Richard E.
Seley, Jane Jeffrie
Stanton, Robert C.
Gabbay, Robert A.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2022-12-12
Volume: 46
Issue: Supplement_1
Pages: S111-S127
ISSN: 0149-5992 (ISSN-L)
DOI: 10.2337/dc23-s007
PMC: PMC9810474
OpenAlex: W4311264017
Cited by: 301
References: 258
Citations by year: 2026: 20 · 2025: 55 · 2024: 132 · 2023: 93 · 2022: 1
FWCI: 10.00
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.diabetesjournals.org/journals/pages/license (vor)
Locations: Diabetes Care (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: diabetes technology, diabetes management, clinical guidelines, quality of care, treatment goals
MeSH terms: Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

7. Diabetes Technology: Standards of Care in Diabetes — 2023

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks